- ASSISTANT PROFESSOR Preventive Medicine
BA, Loyola University Chicago
MA, University of Nebraska at Omaha
MPH, Columbia University
PhD, Columbia Univeristy
Dr. Horton earned her doctoral degree in Environmental Health Sciences at Mailman School of Public Health, Columbia University. During her doctoral training, she gained expertise in the development and use of biological markers to measure prenatal and early life exposures to environmental toxicants, focusing mainly on residential exposure to pesticides. Subsequently, she completed a postdoctoral fellowship at the Sergievsky Center for the Epidemiologic Study of Neurologic Diseases. The focus of this postdoc was to explore the use of brain imaging to investigate the impact of prenatal exposure to pesticides and secondhand smoke on neuropsychological and behavioral function throughout childhood. Dr. Horton was recently awarded an NIH career transition award and accepted a position as an Assistant Professor of Preventive Medicine at Icahn School of Medicine at Mount Sinai. Her current work combines her experience with biomarker development and neuroimaging to understand the mechanisms of neurodevelopmental toxicity following exposure to chemical mixtures.
2011 - 2016
Prenatal exposure to a mixture of endocrine disrupting compounds and child neurodevelopment
Rauh VA, Perera FP, Horton MK, Whyatt RM, Bansal R, Hao X, Liu J, Barr DB, Slotkin TA, Peterson BS. Brain anomalies in children exposed prenatally to a common organophosphate pesticide. Proceedings of the National Academy of Sciences of the United States of America 2012 May; 109(20).
Liu B, Jung KH, Horton MK, Camann DE, Liu X, Reardon AM, Perzanowski MS, Zhang H, Perera FP, Whyatt RM, Miller RL. Prenatal exposure to pesticide ingredient piperonyl butoxide and childhood cough in an urban cohort. Environment international 2012 Nov; 48.
Horton MK, Margolis AE, Tang C, Wright R. Neuroimaging is a novel tool to understand the impact of environmental chemicals on neurodevelopment. Current opinion in pediatrics 2014 Apr; 26(2).
Horton MK, Rundle A, Camann DE, Boyd Barr D, Rauh VA, Whyatt RM. Impact of prenatal exposure to piperonyl butoxide and permethrin on 36-month neurodevelopment. Pediatrics 2011 Mar; 127(3).
Rauh V, Arunajadai S, Horton M, Perera F, Hoepner L, Barr DB, Whyatt R. Seven-year neurodevelopmental scores and prenatal exposure to chlorpyrifos, a common agricultural pesticide. Environmental health perspectives 2011 Aug; 119(8).
Horton MK, Jacobson JB, McKelvey W, Holmes D, Fincher B, Quantano A, Diaz BP, Shabbazz F, Shepard P, Rundle A, Whyatt RM. Characterization of residential pest control products used in inner city communities in New York City. Journal of exposure science & environmental epidemiology; 21(3).
Pérez JJ, Williams MK, Weerasekera G, Smith K, Whyatt RM, Needham LL, Barr DB. Measurement of pyrethroid, organophosphorus, and carbamate insecticides in human plasma using isotope dilution gas chromatography-high resolution mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2010 Oct; 878(27).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Horton did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.
17 East 102 Street Floor 3 Room 136
New York, NY 10029